BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33618986)

  • 1. Analysis of prior authorization success and timeliness at a community-based specialty care pharmacy.
    Hecht B; Frye C; Holland W; Holland CR; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2021; 61(4S):S173-S177. PubMed ID: 33618986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of time to treatment initiation of specialty medications between an integrated health system specialty pharmacy and external specialty pharmacies.
    Russell M; McCoy H; Platt T; Zeltner M; Rhudy C
    J Manag Care Spec Pharm; 2024 Apr; 30(4):352-362. PubMed ID: 38555622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of why some community pharmacists do not provide 72-hour emergency prescription drugs to Medicaid patients when prior authorization is not available.
    Shepherd MD
    J Manag Care Pharm; 2013 Sep; 19(7):523-33. PubMed ID: 23964613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing the costs of developing and operating an integrated health-system specialty pharmacy: The case of a centralized insurance navigation process for specialty clinic patients.
    Rim MH; Thomas KC; Barrus SA; Ryther AMK; Clawson A; Ferrara F; Jackson CG
    Am J Health Syst Pharm; 2021 May; 78(11):982-988. PubMed ID: 33693452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a pharmacy technician-based medication prior authorization program.
    Carico R; West R; Miller T; Brown J; Baum D; Dunaway S; Hill A; Finley W; Bates J; Fenerty J
    J Am Pharm Assoc (2003); 2021; 61(4):425-431. PubMed ID: 33771445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Pharmacy Intervention on Prior Authorization Success and Efficiency at a University Medical Center.
    Cutler T; She Y; Barca J; Lester S; Xing G; Patel J; Melnikow J
    J Manag Care Spec Pharm; 2016 Oct; 22(10):1167-71. PubMed ID: 27668565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specialty pharmacy integration and the role of an advanced certified pharmacy technician in prescription cannabidiol access.
    Owens W; Dial H; DeClercq J; Choi L; Zuckerman AD; Shah NB; Johnson K
    J Am Pharm Assoc (2003); 2022; 62(6):1830-1835. PubMed ID: 35985958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the prior authorization process, patient outcomes, and the impact of a pharmacy intervention: A single-center review.
    Popatia S; Flood KS; Golbari NM; Patel PV; Olbricht SM; Kimball AB; Porter ML
    J Am Acad Dermatol; 2019 Dec; 81(6):1308-1318. PubMed ID: 31103568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embedding an Advanced Pharmacy Technician in an Adult Specialty Pulmonary Clinic to Complete Prior Authorizations Improves Efficiency and Provider Satisfaction.
    Jones EM; Francart SJ; Amerine LB
    J Pharm Pract; 2022 Aug; 35(4):551-558. PubMed ID: 33648372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation and impact assessment of integrated electronic prior authorization in an academic health system.
    Birdsall AD; Kappenman AM; Covey BT; Rim MH
    J Am Pharm Assoc (2003); 2020; 60(4):e93-e99. PubMed ID: 32107157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Patient Care Through Specialty Pharmacy Services in an Academic Health System.
    Bagwell A; Kelley T; Carver A; Lee JB; Newman B
    J Manag Care Spec Pharm; 2017 Aug; 23(8):815-820. PubMed ID: 28737983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of embedding a pharmacist in a dermatology clinic on outcomes in a specialty pharmacy.
    Penick T; Hawkins T; O'Reilly E; Maniyar H; Maier C; McPheeters C
    J Am Pharm Assoc (2003); 2023; 63(2):661-666. PubMed ID: 36464555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Provision of ambrisentan from a health-system specialty pharmacy affiliated with a pulmonary hypertension Center of Comprehensive Care.
    Gutenschwager DW; Patel A; Soyad AT; Patel S; Szandzik EG; Kelly B; Smith ZR
    Am J Health Syst Pharm; 2024 Jan; 81(2):66-73. PubMed ID: 37611180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pharmacy services on cystic fibrosis transmembrane conductance regulator modulator prescribing at a pediatric cystic fibrosis center.
    Wright BA; Singh SB; Schultz JL; Ramsey LJ; Spading KA; Mascardo LA; Starner TD
    Pediatr Pulmonol; 2019 Oct; 54(10):1591-1595. PubMed ID: 31294925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialty pharmacy turnaround time impediments, facilitators, and good practices.
    Gabriel MH; Kotschevar CM; Tarver D; Mastrangelo V; Pezzullo L; Campbell PJ
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1244-1251. PubMed ID: 36282928
    [No Abstract]   [Full Text] [Related]  

  • 16. Development of a process to improve medication adherence in patients with rheumatoid arthritis in the specialty pharmacy setting.
    Amado AY; Frye C; Holland W; Holland CR; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2020; 60(3S):S61-S64.e1. PubMed ID: 32446651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing Access to Hepatitis C Virus Medications: A Program Model Using Patient Navigators and Specialty Pharmacy to Obtain Prior Authorization Approval.
    Vu TM; Toribio W; Riazi F; Ciprian G; Gibbs N; Giardina M; Camacho JA; Parrella K; Cambe J; Amory C; Chasan R; Sigel KM; Weiss JJ
    J Manag Care Spec Pharm; 2018 Apr; 24(4):329-333. PubMed ID: 29578854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy.
    Peter ME; Markley B; DeClercq J; Choi L; Givens G; Zuckerman AD; Banks A
    J Manag Care Spec Pharm; 2021 Feb; 27(2):256-262. PubMed ID: 33506731
    [No Abstract]   [Full Text] [Related]  

  • 19. Perceptions of prior authorization by use of electronic prior authorization software: A survey of providers in the United States.
    Salzbrenner SG; McAdam-Marx C; Lydiatt M; Helding B; Scheier LM; Hill PW
    J Manag Care Spec Pharm; 2022 Oct; 28(10):1121-1128. PubMed ID: 36125058
    [No Abstract]   [Full Text] [Related]  

  • 20. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
    Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.